Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07214168 · ClinicalTrials.gov registry record
Vape Use Among Younger & Older Smokers
A clinical trial of Smoking Behaviors and Smoking, Cigarette, sponsored by Abramson Cancer Center at Penn Medicine.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT07214168: Recruiting study of Smoking Behaviors and Smoking, Cigarette, sponsored by Abramson Cancer Center at Penn Medicine.
NCT07214168 is a study of Smoking Behaviors and Smoking, Cigarette that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 100 participants, below the 434-participant average among 21 other Smoking Behaviors trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07214168, a study of Smoking Behaviors and Smoking, Cigarette, is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to recruit 100 current cigarette smokers (50 young adults ages 21-34; 50 older adults ages 35-65) who have tried vaping or are currently vaping (dual users). The study will examine the trajectories in tobacco use (cigarettes and/or ENDS), including the nuanced differences in ENDS use (i.e., detailed device characteristics, user preferences, patterns of use), according to smoker age group.
Primary Outcome
Participants will be asked to create an account for a mobile application that will serve as a digital diary to track any potential changes in tobacco product use, specifically ENDS and cigarette use, frequency of use for both products, and reasons for this change. The mobile app will ask the participant on a weekly basis whether there was any change to smoking and vaping habits from the past week. Collection of weekly data will provide granularity and a better understanding of the nuanced differ
Conditions Studied
Study Locations (1)
Pennsylvania
- Center for Interdisciplinary Research on Nicotine Addiction - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-09-05 |
| Est. Completion | 2026-07 |
What NCT07214168 shows while recruiting
NCT07214168 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 434-participant average among 21 other Smoking Behaviors trials with a reported enrollment target (77% lower).
The record links to 4 conditions, with Smoking Behaviors appearing as the primary indexed condition, and to 0 interventions.
NCT07214168 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07214168 about?
NCT07214168 is a clinical study titled "Vape Use Among Younger & Older Smokers". The study aims to recruit 100 current cigarette smokers (50 young adults ages 21-34; 50 older adults ages 35-65) who have tried vaping or are currently vaping (dual users). The study will examine the trajectories in tobacco use (cigarettes and/or ENDS), including the nuanced differences in ENDS use ...
What is the current status of trial NCT07214168?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-09-05. Estimated completion is 2026-07.
What conditions does trial NCT07214168 study?
This clinical trial studies the following conditions: Smoking Behaviors, Smoking, Cigarette, Vaping, Vaping Behaviors.
Who is sponsoring clinical trial NCT07214168?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07214168 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Behaviors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07214168's enrollment target sits among peer trials
100 15th of 21 higher than 7 of 21 other Smoking Behaviors trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Behaviors trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
RECRUITING · NA
-
Overcoming Nicotine Dependence to Enable Quitting
RECRUITING · Phase 1
-
Take A Break - Rural
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI